Karuna Therapeutics (KRTX) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
02M5M8M10M12M15M18M20MQ4 2022Q1 2023Q2 2023Q3 2023Q4 2023

Margin (%)

Gross MarginOperating MarginNet Income Margin
0255075100125150175200Q4 2022Q1 2023Q2 2023Q3 2023Q4 2023

Operating Expenses

Research And Development ExpensesGeneral And Administrative ExpensesOther Expenses
025M50M75M100M125M150M175M200MQ4 2022Q1 2023Q2 2023Q3 2023Q4 2023

EBITDA

EBITDA
-200M-175M-150M-125M-100M-75M-50M-25M1Q4 2022Q1 2023Q2 2023Q3 2023Q4 2023

EPS

Revenue Variation (%)

Revenue Variation
-2008252K3K4K5K6K7K8KQ4 2022Q1 2023Q2 2023

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
0612192531384450Q4 2022Q1 2023Q2 2023Q3 2023Q4 2023

Revenue YoY Variation (%)

Revenue YoY Variation
-200-175-150-125-100-74-49-241Q4 2022Q2 2023Q3 2023Q4 2023

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
062125188250312375438500Q4 2022Q1 2023Q2 2023Q3 2023Q4 2023

Price-to-Earning Ratio

P/E Ratio
-40-35-30-25-20-14-9-41Q4 2022Q1 2023Q2 2023Q3 2023Q4 2023

Income Breakdown

Per Share Metrics

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
05M10M15M20M25M30M35M40MQ4 2022Q1 2023Q2 2023Q3 2023Q4 2023

Expense Ratios

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
000001111Q4 2022Q1 2023Q2 2023Q3 2023Q4 2023
💰 Cash Flow Statement

Operating Cash Flow

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
0255075100125150175200Q4 2022Q1 2023Q2 2023Q3 2023Q4 2023

Free Cash Flow

Cash Flow to Debt Ratio

Cash At End Of Period
088M175M262M350M438M525M612M700MQ4 2022Q1 2023Q2 2023Q3 2023Q4 2023
🏦 Balance Sheet
📈 Key Metrics